KalVista Pharmaceuticals
KALV
KALV
91 hedge funds and large institutions have $237M invested in KalVista Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.31% less ownership
Funds ownership: 99.16% → 98.85% (-0.31%)
35% less capital invested
Capital invested by funds: $364M → $237M (-$126M)
Holders
91
Holding in Top 10
3
Calls
$6M
Puts
–
Top Buyers
| 1 | +$11.3M | |
| 2 | +$7.59M | |
| 3 | +$6.45M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$5.8M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.02M |
Top Sellers
| 1 | -$38.7M | |
| 2 | -$28.5M | |
| 3 | -$18.3M | |
| 4 |
DM
Deerfield Management
New York
|
-$12.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.63M |